On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.
On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.
To cope with a growing shortage of hearts, livers, and lungs suitable for transplant, some scientists are genetically engineering pigs, while others are growing organs in the lab.
As we stand on the brink of a new scientific age, how researchers should best communicate their findings and innovations is hotly debated in the publishing trenches.
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
Research is underway to reduce the use of food crops for biofuels by shifting to dedicated energy crops and agricultural residues.
More than simply helping haul out a cell’s garbage, ubiquitin, with its panoply of chain lengths and shapes, marks and regulates many unrelated cellular processes.
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.
After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.
What can a twentysomething naked mole-rat tell us about fighting pain, cancer, and aging?
What lies untapped beneath the surface of published clinical trial analyses could rock the world of independent review.